Table 2.
Demonstrating comparative summary of Euroqol 5-dimension-5 level questionnaire and EQ-(VAS) best health score in the patients at 1, 3, 6 and 12 months
| EQ-5D-5LDimension | 1 month | 3 month | 6 months | 12 months | P value |
|---|---|---|---|---|---|
| Mobility (Median) | 4 (IQR-1) | 3 (IQR-1) | 2( IQR-1) | 1 (IQR-0) | < 0.01a |
| Self-care (Median) | 4 (IQR-1.25) | 2(IQR-1) | 1(IQR-1) | 1(IQR-0) | < 0.01 |
| Usual activities (Median) | 4 (IQR -2) | 3 (IQR-1) | 2 (IQR-1) | 1 (IQR-0) | < 0.01 |
| Pain/Discomfort (Median) | 4( IQR-1) | 3 (IQR-1) | 1(IQR-1) | 1 (IQR-1) | < 0.01 |
| Anxiety/Depression (Median) | 3 (IQR-1) | 1 (IQR-2) | 1 (IQR-0.5) | 1 (IQR*0) | < 0.01 |
| EQ-VAS (best health scores) (Mean) | 40.60 | 63.60 | 80.16 | 92.40 | < 0.001 |
| Mean KSS Objective (Maximum score 100) | 33.43 | 58.62 | 74.38 | < 0.01b | |
| Function (Maximum score 100) | 14.25 | 55.50 | 72.75 | < 0.01b |
EQ-5D-5L Euroqol 5 Dimension 5 Level Questionnaire, EQ-VAS Euroqol Visual Analog Scale, KSS Knee society score
aComparison of median scores at all time frames was done with Friedman’s test
bComparison of mean scores at all time frames was done with Greenhouse–Geisser test